Register for American Lung Association’s Public Health Roadmap: Systems Change Strategies to Address Youth Cessation Webcast on Tuesday, September 28, 2021, at 11 am CST. Tobacco use by adolescents and ...
November is Lung Cancer Awareness Month! Lung cancer is one of the most common causes of death for individuals with mental health and substance use challenges. Fear and isolation brought ...
Justice-involved individuals are more likely to present with mental health and substance use challenges and use tobacco at high rates. Implementing evidence-based tobacco cessation strategies within correctional systems can reduce health disparities ...
Join APPEAL (Asian Pacific Partners Empowerment, Advocacy, and Leadership) and a panel of experts from the Networking2Save CDC National Networks on Thursday, December 16th at 12 pm ET as we ...
Smoke-free environments in mental health and substance use treatment organizations can reduce tobacco use among these individuals and improve the health of the staff, and yet many mental health and ...
In the U.S., 34% of adults with mental health challenges who use tobacco identify as Black, and 32% identify as Hispanic/Latinx. Understanding this relationship between mental health and substance use ...
Description On February 10, 2022, the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) is holding a public webinar titled “FDA’s Rulemaking Process and Planned Tobacco Product ...
Varenicline, an FDA-approved prescription smoking cessation aid, is an effective evidence-based treatment for reducing tobacco use among individuals with mental health and substance use challenges. Join the National Behavioral Health ...
